BioMark Diagnostics Inc.

BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the detection and quantitation of metabolites. Our global enterprise team of proven scientists, engineers and medical professionals is hand-picked. The company’s goal is to commercialize our innovative technology. And we strive to increase the predictive accuracy in early stage cancer detection. We adhere to and follow the highest regulatory, clinical and scientific standards. Since 2007, our mission and team commitment remains the same. Develop and commercialize innovative technologies. Increase the prediction and accuracy of early stage diagnosis of cancers.